Sticking to Business, Affymetrix, Illumina Offer Glimpse of ‘08 in Third-Quarter Calls

Both Illumina and Affymetrix saw a surge in instrumentation sales during the third quarter as well as continued uptake of their microarray products for both gene expression and genotyping. The firms also provided updates on their relationships with personal genetics companies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.